Outlook Therapeutics (OTLK) Inventory (2024 - 2026)
Outlook Therapeutics (OTLK) reported Inventory of $3.3 million for Q1 2026, down 7.22% year-over-year from $3.6 million in Q1 2025, and down 3.29% quarter-over-quarter from $3.5 million in Q4 2025.
Outlook Therapeutics (OTLK) Inventory (2024 - 2026) Analysis & Trends
Outlook Therapeutics (OTLK) has 3 years of Inventory data on file, last reported at $3.3 million in Q1 2026.
- Inventory for Q1 2026 came in at $3.3 million, down 7.22% year-over-year; the trailing twelve-month figure through Mar 2026 was $3.3 million (down 7.22% YoY), and the FY2025 annual result was $3.3 million, changed N/A from the prior year.
- Inventory retreated to $3.3 million in Q1 2026 per OTLK's latest filing, from $3.5 million in the prior quarter.
- Over five years, Inventory peaked at $4.1 million in Q2 2025 and troughed at $3.1 million in Q4 2024.
- A 3-year average of $3.5 million and a median of $3.4 million in 2025 frame the typical range for Inventory.
- The sharpest annual moves came in 2025 and 2026: Inventory rose 11.21% in 2025, then decreased 7.22% in 2026.
- A 3-year view of Inventory shows it stood at $3.1 million in 2024, then advanced by 11.21% to $3.5 million in 2025, then slipped by 3.29% to $3.3 million in 2026.
- Business Quant data shows OTLK's Inventory at $3.3 million in Q1 2026, $3.5 million in Q4 2025, and $3.3 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 788,338.31 Bn | 788,338.28 Bn | - | - |
| 2 | Belite Bio | 56,560.00 Bn | 56,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,329.30 Bn | 17,329.30 Bn | - | - |
| 4 | Legend Biotech | 3,341.00 Bn | 3,340.71 Bn | 242.10 Mn | 32.00 Mn |
| 5 | Akari Therapeutics | 1,727.91 Bn | 1,727.91 Bn | - | - |
| 6 | Evaxion A | 1,536.68 Bn | 1,536.67 Bn | - | - |
| 7 | Psyence Biomedical | 238.34 Bn | 238.33 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.42 Bn | 106.17 Bn | 2.59 Bn | 1.77 Bn |
| 9 | Abivax | 95.45 Bn | 95.45 Bn | - | - |
| 10 | Outlook Therapeutics | 51.13 Mn | 43.39 Mn | -21,888.00 | 3.34 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3.34 Mn |
| Dec 31, 2025 | 3.46 Mn |
| Sep 30, 2025 | 3.34 Mn |
| Jun 30, 2025 | 4.13 Mn |
| Mar 31, 2025 | 3.60 Mn |
| Dec 31, 2024 | 3.11 Mn |